Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Psychoneuroendocrinology

• Publication date

  2014-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psyneuen.2014.03.012PMID 24845180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The stress-axis in multiple sclerosis: Clinical, cellular, and molecular aspects.

  2021cited by this paper
• Dexamethasone inhibits the maturation of newly formed neurons and glia supplemented with polyunsaturated fatty acids.

  2013cited by this paper
• Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.

  2009cited by this paper
• Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis

  2008cited by this paper
• Acute and chronic neuroendocrine effects of interferon‐β 1a in multiple sclerosis

  2007cited by this paper
• Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

  2006cited by this paper
• Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity.

  2005cited by this paper
• Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.

  2005cited by this paper
• Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.

  2005cited by this paper
• McAlpine's Multiple Sclerosis

  2005cited by this paper
• Impaired hypothalamus‐pituitary‐adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions

  2004cited by this paper
• Neuroendocrine regulation of immunity.

  2003cited by this paper
• Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.

  2002cited by this paper
• Activity of the hypothalamic–pituitary–adrenal axis in multiple sclerosis: Correlations with gadolinium‐enhancing lesions and ventricular volume

  2002cited by this paper
• Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS

  2000cited by this paper
• Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS

  1999cited by this paper
• Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

  1998cited by this paper
• The neuroendocrine axis in patients with multiple sclerosis.

  1997cited by this paper
• Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis.

  1995cited by this paper
• Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis.

  1995cited by this paper
• Adrenal size is increased in multiple sclerosis.

  1994cited by this paper
• Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.

  1994cited by this paper
• Inhibition of interleukin-2-mediated lymphocyte activation in patients with Cushing's syndrome: a comparison with hypocortisolemic patients.

  1994cited by this paper
• Dexamethasone suppression test abnormalities in multiple sclerosis

  1987cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper

• Assessment of Serum ACTH, Melatonin, and Cortisol Levels in Patients with Hormone Imbalance and Multiple Sclerosis.

  2025cites this paper
• Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids

  2024cites this paper
• Mineralocorticoid Receptor Signaling in Peripheral Blood Cells in Patients with Multiple Sclerosis

  2024cites this paper
• HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls

  2022cites this paper
• Impact of the covid-19 pandemic on the psychological status and cortisol level of multiple sclerosis patients

  2022cites this paper
• Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response

  2021cites this paper
• RehaCom rehabilitation training improves a wide-range of cognitive functions in multiple sclerosis patients

  2020cites this paper
• Inflammatory Conditions of the Hypothalamus

  2020cites this paper
• Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications

  2020cites this paper
• Plasma copeptin levels in patients with multiple sclerosis.

  2020cites this paper
• Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis

  2019cites this paper
• Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?

  2019cites this paper
• Hyperstable arousal regulation in multiple sclerosis.

  2019cites this paper
• Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?

  2018cites this paper
• Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.

  2018cites this paper
• Importancia del glutamato en las funciones neuroendocrinológicas en la esclerosis múltiple relacionadas con la fatiga

  2018influential citation
• Is there a link between inflammation and fatigue in multiple sclerosis?

  2018cites this paper
• Basal cortisol levels and the relationship with clinical symptoms in multiple sclerosis: a systematic review

  2018cites this paper
• Metabolic treatment of syndrome linked with Parkinson's disease and hypothalamus pituitary gonadal hormones by turmeric curcumin in Bisphenol-A induced neuro-testicular dysfunction of wistar rat

  2018cites this paper
• Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.

  2017cites this paper
• Type D, in Association with Quality of Life in Patients with Multiple Sclerosis

  2017cites this paper
• Fatigue in multiple sclerosis - Insights into evaluation and management.

  2017cites this paper
• Neuroimmune Regulation in Health and Disease

  2016cites this paper
• What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.

  2016cites this paper
• Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients.

  2015cites this paper
• ehavioural changes observed in demyelination model shares imilarities with white matter abnormalities in humans athalia

  2015cites this paper
• Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis.

  2014cites this paper